array(63) { ["SERVER_SOFTWARE"]=> string(6) "Apache" ["REQUEST_URI"]=> string(54) "/instituto/idorpost_scientists/maria-ignez-braghiroli/" ["PHP_PATH"]=> string(24) "/opt/bitnami/php/bin/php" ["FREETDSLOCALES"]=> string(0) "" ["FREETDSCONF"]=> string(0) "" ["OPENSSL_ENGINES"]=> string(31) "/opt/bitnami/common/lib/engines" ["OPENSSL_CONF"]=> string(39) "/opt/bitnami/common/openssl/openssl.cnf" ["SSL_CERT_FILE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["CURL_CA_BUNDLE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["LDAPCONF"]=> string(42) "/opt/bitnami/common/etc/openldap/ldap.conf" ["GS_LIB"]=> string(43) "/opt/bitnami/common/share/ghostscript/fonts" ["MAGICK_CODER_MODULE_PATH"]=> string(60) "/opt/bitnami/common/lib/ImageMagick-6.9.8/modules-Q16/coders" ["MAGICK_CONFIGURE_PATH"]=> string(73) "/opt/bitnami/common/lib/ImageMagick-6.9.8/config-Q16:/opt/bitnami/common/" ["MAGICK_HOME"]=> string(19) "/opt/bitnami/common" ["PATH"]=> string(260) "/opt/bitnami/apps/wordpress/bin:/opt/bitnami/varnish/bin:/opt/bitnami/sqlite/bin:/opt/bitnami/php/bin:/opt/bitnami/mysql/bin:/opt/bitnami/letsencrypt/:/opt/bitnami/apache2/bin:/opt/bitnami/common/bin:/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin" ["USER"]=> string(6) "daemon" ["HOME"]=> string(9) "/usr/sbin" ["SCRIPT_NAME"]=> string(10) "/index.php" ["QUERY_STRING"]=> string(0) "" ["REQUEST_METHOD"]=> string(3) "GET" ["SERVER_PROTOCOL"]=> string(8) "HTTP/1.0" ["GATEWAY_INTERFACE"]=> string(7) "CGI/1.1" ["REDIRECT_URL"]=> string(54) "/instituto/idorpost_scientists/maria-ignez-braghiroli/" ["REMOTE_PORT"]=> string(5) "21921" ["SCRIPT_FILENAME"]=> string(44) "/opt/bitnami/apps/wordpress/htdocs/index.php" ["SERVER_ADMIN"]=> string(15) "[email protected]" ["CONTEXT_DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["CONTEXT_PREFIX"]=> string(0) "" ["REQUEST_SCHEME"]=> string(4) "http" ["DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["REMOTE_ADDR"]=> string(14) "54.207.195.110" ["SERVER_PORT"]=> string(2) "80" ["SERVER_ADDR"]=> string(11) "172.26.1.14" ["SERVER_NAME"]=> string(13) "54.225.48.228" ["SERVER_SIGNATURE"]=> string(0) "" ["LD_LIBRARY_PATH"]=> string(410) "/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/varnish/lib:/opt/bitnami/varnish/lib/varnish:/opt/bitnami/varnish/lib/varnish/vmods:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/common/lib64" ["HTTP_ACCEPT_LANGUAGE"]=> string(14) "en-US,en;q=0.5" ["HTTP_ACCEPT"]=> string(63) "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8" ["HTTP_USER_AGENT"]=> string(40) "CCBot/2.0 (https://commoncrawl.org/faq/)" ["HTTP_CF_VISITOR"]=> string(22) "{\"scheme\":\"https\"}" ["HTTP_CF_IPCOUNTRY"]=> string(2) "US" ["HTTP_TRUE_CLIENT_IP"]=> string(11) "100.28.2.72" ["HTTP_CF_RAY"]=> string(20) "898472c46b775866-GRU" ["HTTP_ACCEPT_ENCODING"]=> string(8) "gzip, br" ["HTTP_CDN_LOOP"]=> string(10) "cloudflare" ["HTTP_CF_CONNECTING_IP"]=> string(11) "100.28.2.72" ["HTTP_X_AMZN_TRACE_ID"]=> string(40) "Root=1-667813b4-05de10c75ecd17c912cdd155" ["HTTP_X_FORWARDED_PORT"]=> string(3) "443" ["HTTP_CONNECTION"]=> string(5) "close" ["HTTP_X_FORWARDED_PROTO"]=> string(4) "http" ["HTTP_X_FORWARDED_FOR"]=> string(39) "100.28.2.72, 172.71.6.51, 10.247.46.155" ["HTTP_X_REAL_IP"]=> string(13) "10.247.46.155" ["HTTP_X_FORWARDED_HOST"]=> string(25) "www.rededorsaoluiz.com.br" ["HTTP_HOST"]=> string(13) "54.225.48.228" ["SCRIPT_URI"]=> string(74) "http://54.225.48.228/instituto/idorpost_scientists/maria-ignez-braghiroli/" ["SCRIPT_URL"]=> string(54) "/instituto/idorpost_scientists/maria-ignez-braghiroli/" ["REDIRECT_STATUS"]=> string(3) "200" ["REDIRECT_SCRIPT_URI"]=> string(74) "http://54.225.48.228/instituto/idorpost_scientists/maria-ignez-braghiroli/" ["REDIRECT_SCRIPT_URL"]=> string(54) "/instituto/idorpost_scientists/maria-ignez-braghiroli/" ["FCGI_ROLE"]=> string(9) "RESPONDER" ["PHP_SELF"]=> string(10) "/index.php" ["REQUEST_TIME_FLOAT"]=> float(1719145396.5394) ["REQUEST_TIME"]=> int(1719145396) }

Maria Ignez Braghiroli

Maria Ignez Braghiroli

Médica formada pela Universidade Federal da Bahia,  oncologista clínica formada pela Universidade de São Paulo e com especialização em tumores do trato gastrointestinal pelo Memorial Sloan Kettering. Dedicada ao cuidado integral do paciente em conjunto com equipe multidisciplinar. Interesse especial em pesquisa clínica e avanços na terapia oncológica.

Palavras-chave: Câncer gastrointestinal; pesquisa clínica; câncer colorretal

PESQUISA

Médica do Instituto do Câncer do Estado de São Paulo

Médica titular na Rede D´Or

Coordenadora da Residência em Oncologia da Rede D´Or em São Paulo

ÁREAS DE PESQUISA

INFORMAÇÕES ADICIONAIS

Prêmios e Títulos

1° lugar da categoria "Doutorado pré-qualificação" da Jornada de Oncologia - FMUSP 2022

Publicações Selecionadas

Braghiroli MI, Sabbaga J, Hoff PM. Bevacizumab: overview of the literature. Expert Rev Anticancer Ther. 2012 May;12(5):567-80. PMID: 22594892.

Doki, Y., Ajani, J. A., Kato, K., Xu, J., Wyrwicz, L., Motoyama, S., Ogata, T., Kawakami, H., Hsu, C.-H., Adenis, A., El Hajbi, F., Di Bartolomeo, M., Braghiroli, M. I., et al. Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. New England Journal of Medicine, 2022, 386(5), 449–462.

Tabernero J, Van Cutsem E, Bang Y-J, Fuchs CS, Wyrwicz L, Lee KW, Kubada I, Garrido M, Chung HC, Salguero HRC, Mansoor W, Braghiroli MIFM, et al. Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study. Journal of Clinical Oncology. 2019 Jun 20;37(18_suppl):LBA4007–7.

Connell LC, Mota JM, Braghiroli MI, Hoff PM. The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment. Curr Treat Options Oncol. 2017 Apr;18(4):23. PMID: 28391421.

Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Mansoor W, Braghiroli MI, et al. Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020 Oct 1;6(10):1571-1580. PMID: 32880601; PMCID: PMC7489405.

Conteúdo Relacionado
Fale com a gente.